Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Inference of SARS-CoV-2 exposure biomarkers using large-scale T-cell repertoire profiling.
PMID 41680899 · PMC12903587 · Genome medicine · 2026 · 7 claims · 6 setups
A novel batch-effect correction method (log-normal gene usage modeling, Z-score normalization, and roulette-wheel resampling) allows combining AIRR-seq data from different batches and protocols.
-
Full-text index only
T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant.
PMID 8666925 · PMC2192525 · The Journal of experimental medicine · 1996 · 8 claims · 6 setups
Despite heterogeneous TCR usage among clones from different HLA-B14 subjects, the fine specificity for the gp41/584-592 epitope and its variants is strikingly similar.
-
Full-text index only
A pan-cancer single cell landscape reveals heterogeneity and functional diversity of double-negative T cells.
PMID 41484771 · PMC12882460 · Molecular cancer · 2026 · 7 claims · 5 setups
Integration of pan-cancer scRNA-seq data yields a comprehensive single-cell atlas of 157,025 high-quality DNT cells across 23 cancer types.
-
Full-text index only
Generation of thymus-reconstituting T cell progenitors from human pluripotent stem cells.
PMID 41512861 · PMC12853186 · Cell reports methods · 2026 · 7 claims · 6 setups
A cytokine-free hPSC hematopoietic differentiation protocol followed by OP9-DLL4 stromal co-culture generates pro-T cells without genetic manipulation
-
Full-text index only
Regulatory-like FOXP3+Helios+CD4+ T conventional cells correlate with T-cell activation after Orca-T immunotherapy.
PMID 41758930 · PMC13197979 · Blood · 2026 · 8 claims · 6 setups
Orca-T immunotherapy leads to increased phenotypic T-cell activation compared with unmanipulated PBSC grafts, persisting for months after treatment.